BindingDB logo
myBDB logout

Patent code US9790174

Compile Data Set for Download or QSAR

Found 318 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256521
PNG
(US9481648, 20 | US9790174, Example 20)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(C(N)=O)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C41H48N6O9/c1-41(2,3)26-21-32(38(42)48)37(52-6)34(22-26)46-40(49)45-33-11-12-35(31-10-8-7-9-30(31)33)56-36-13-14-43-39(47-36)44-27-23-28(51-5)25-29(24-27)55-20-19-54-18-17-53-16-15-50-4/h7-14,21-25H,15-20H2,1-6H3,(H2,42,48)(H,43,44,47)(H2,45,46,49)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 6n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256511
PNG
(US9481648, 9 | US9790174, Example 9)
Show SMILES CNC(=O)c1cc(cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(cc(c4)C(=O)NCCN4CCOCC4)C#C)n3)c3ccccc23)c1OC)C(C)(C)C
Show InChI InChI=1S/C43H46N8O6/c1-7-27-22-28(39(52)45-16-17-51-18-20-56-21-19-51)24-30(23-27)47-41-46-15-14-37(50-41)57-36-13-12-34(31-10-8-9-11-32(31)36)48-42(54)49-35-26-29(43(2,3)4)25-33(38(35)55-6)40(53)44-5/h1,8-15,22-26H,16-21H2,2-6H3,(H,44,53)(H,45,52)(H,46,47,50)(H2,48,49,54)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 8n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256515
PNG
(US9481648, 13 | US9790174, Example 13)
Show SMILES CNC(=O)c1cc(cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(OCCOCCOCCOC)c4)n3)c3ccccc23)c1OC)C(C)(C)C
Show InChI InChI=1S/C42H50N6O9/c1-42(2,3)27-22-33(39(49)43-4)38(53-7)35(23-27)47-41(50)46-34-12-13-36(32-11-9-8-10-31(32)34)57-37-14-15-44-40(48-37)45-28-24-29(52-6)26-30(25-28)56-21-20-55-19-18-54-17-16-51-5/h8-15,22-26H,16-21H2,1-7H3,(H,43,49)(H,44,45,48)(H2,46,47,50)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 9n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM347466
PNG
(3-((4-((4-(3-(5-(tert-Butyl)-2-methoxy-3-(methylsu...)
Show SMILES CNc1cc(cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(c4)C(=O)NCCOCCOCCOC)n3)c3ccccc23)c1OC)C(C)(C)C
Show InChI InChI=1S/C42H51N7O8/c1-42(2,3)28-24-34(43-4)38(54-7)35(25-28)48-41(51)47-33-12-13-36(32-11-9-8-10-31(32)33)57-37-14-15-45-40(49-37)46-29-22-27(23-30(26-29)53-6)39(50)44-16-17-55-20-21-56-19-18-52-5/h8-15,22-26,43H,16-21H2,1-7H3,(H,44,50)(H,45,46,49)(H2,47,48,51)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 9n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256519
PNG
(US9481648, 18 | US9790174, Example 18)
Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(NS(C)(=O)=O)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OCCOCCOCCN2CCOCC2)c1
Show InChI InChI=1S/C44H55N7O10S/c1-44(2,3)30-25-37(41(56-5)38(26-30)50-62(6,53)54)48-43(52)47-36-11-12-39(35-10-8-7-9-34(35)36)61-40-13-14-45-42(49-40)46-31-27-32(55-4)29-33(28-31)60-24-23-59-22-21-58-20-17-51-15-18-57-19-16-51/h7-14,25-29,50H,15-24H2,1-6H3,(H,45,46,49)(H2,47,48,52)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 10n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256534
PNG
(US9481648, 33 | US9790174, Example 33)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(C(=O)NC5CC5)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C44H52N6O9/c1-44(2,3)28-23-35(41(51)46-29-11-12-29)40(55-6)37(24-28)49-43(52)48-36-13-14-38(34-10-8-7-9-33(34)36)59-39-15-16-45-42(50-39)47-30-25-31(54-5)27-32(26-30)58-22-21-57-20-19-56-18-17-53-4/h7-10,13-16,23-27,29H,11-12,17-22H2,1-6H3,(H,46,51)(H,45,47,50)(H2,48,49,52)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 11n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256524
PNG
(US9481648, 23 | US9790174, Example 23)
Show SMILES CNC(=O)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(OCCOCCOCCOC)c4)n3)c3ccccc23)cc(c1)C(C)(C)C
Show InChI InChI=1S/C41H48N6O8/c1-41(2,3)28-21-27(38(48)42-4)22-29(23-28)45-40(49)46-35-11-12-36(34-10-8-7-9-33(34)35)55-37-13-14-43-39(47-37)44-30-24-31(51-6)26-32(25-30)54-20-19-53-18-17-52-16-15-50-5/h7-14,21-26H,15-20H2,1-6H3,(H,42,48)(H,43,44,47)(H2,45,46,49)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 11n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM347465
PNG
(3-((4-((4-(3-(5-(tert-Butyl)-2-methoxy-3-(methylsu...)
Show SMILES CNc1cc(cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(c4)C(=O)NCCN4CCOCC4)n3)c3ccccc23)c1OC)C(C)(C)C
Show InChI InChI=1S/C41H48N8O6/c1-41(2,3)27-23-33(42-4)37(53-6)34(24-27)47-40(51)46-32-11-12-35(31-10-8-7-9-30(31)32)55-36-13-14-44-39(48-36)45-28-21-26(22-29(25-28)52-5)38(50)43-15-16-49-17-19-54-20-18-49/h7-14,21-25,42H,15-20H2,1-6H3,(H,43,50)(H,44,45,48)(H2,46,47,51)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 11n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256516
PNG
(US9481648, 14 | US9790174, Example 14)
Show SMILES COCCOCCOCCOCCOCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(NS(C)(=O)=O)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C49H66N6O14S/c1-49(2,3)35-30-42(46(61-6)43(31-35)55-70(7,57)58)53-48(56)52-41-12-13-44(40-11-9-8-10-39(40)41)69-45-14-15-50-47(54-45)51-36-32-37(60-5)34-38(33-36)68-29-28-67-27-26-66-25-24-65-23-22-64-21-20-63-19-18-62-17-16-59-4/h8-15,30-34,55H,16-29H2,1-7H3,(H,50,51,54)(H2,52,53,56)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 11n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM256524
PNG
(US9481648, 23 | US9790174, Example 23)
Show SMILES CNC(=O)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(OCCOCCOCCOC)c4)n3)c3ccccc23)cc(c1)C(C)(C)C
Show InChI InChI=1S/C41H48N6O8/c1-41(2,3)28-21-27(38(48)42-4)22-29(23-28)45-40(49)46-35-11-12-36(34-10-8-7-9-33(34)35)55-37-13-14-43-39(47-37)44-30-24-31(51-6)26-32(25-30)54-20-19-53-18-17-52-16-15-50-5/h7-14,21-26H,15-20H2,1-6H3,(H,42,48)(H,43,44,47)(H2,45,46,49)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 11n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The following two assay variants can be used for determination of p38 MAPKα inhibition.Method 1The inhibitory activities of test compounds again...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256503
PNG
(US9481648, 1 | US9790174, Example 1)
Show SMILES COc1c(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(cc(c4)C(=O)NCCN4CCOCC4)C#C)n3)c3ccccc23)cc(cc1NS(C)(=O)=O)C(C)(C)C
Show InChI InChI=1S/C42H46N8O7S/c1-7-27-22-28(39(51)43-16-17-50-18-20-56-21-19-50)24-30(23-27)45-40-44-15-14-37(48-40)57-36-13-12-33(31-10-8-9-11-32(31)36)46-41(52)47-34-25-29(42(2,3)4)26-35(38(34)55-5)49-58(6,53)54/h1,8-15,22-26,49H,16-21H2,2-6H3,(H,43,51)(H,44,45,48)(H2,46,47,52)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 12n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256538
PNG
(US9481648, 37 | US9790174, Example 37)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(C(=O)NCC(=O)OC)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C44H52N6O11/c1-44(2,3)28-22-34(41(52)46-27-39(51)56-6)40(57-7)36(23-28)49-43(53)48-35-12-13-37(33-11-9-8-10-32(33)35)61-38-14-15-45-42(50-38)47-29-24-30(55-5)26-31(25-29)60-21-20-59-19-18-58-17-16-54-4/h8-15,22-26H,16-21,27H2,1-7H3,(H,46,52)(H,45,47,50)(H2,48,49,53)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 12n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256570
PNG
(US9481648, 69 | US9790174, Example 69)
Show SMILES CCOc1c(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(OCCOCCOCCOC)c4)n3)c3ccccc23)cc(cc1NS(C)(=O)=O)C(C)(C)C
Show InChI InChI=1S/C42H52N6O10S/c1-8-56-39-35(23-28(42(2,3)4)24-36(39)48-59(7,50)51)46-41(49)45-34-13-14-37(33-12-10-9-11-32(33)34)58-38-15-16-43-40(47-38)44-29-25-30(53-6)27-31(26-29)57-22-21-55-20-19-54-18-17-52-5/h9-16,23-27,48H,8,17-22H2,1-7H3,(H,43,44,47)(H2,45,46,49)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 13n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256536
PNG
(US9481648, 35 | US9790174, Example 35)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(C(=O)NCCO)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C43H52N6O10/c1-43(2,3)28-23-34(40(51)44-15-16-50)39(55-6)36(24-28)48-42(52)47-35-11-12-37(33-10-8-7-9-32(33)35)59-38-13-14-45-41(49-38)46-29-25-30(54-5)27-31(26-29)58-22-21-57-20-19-56-18-17-53-4/h7-14,23-27,50H,15-22H2,1-6H3,(H,44,51)(H,45,46,49)(H2,47,48,52)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
US Patent
n/an/a 13n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256525
PNG
(US9481648, 24 | US9790174, Example 24)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(NS(C)(=O)=O)cc(c4)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C40H48N6O9S/c1-40(2,3)27-21-28(23-30(22-27)46-56(6,48)49)43-39(47)44-35-11-12-36(34-10-8-7-9-33(34)35)55-37-13-14-41-38(45-37)42-29-24-31(51-5)26-32(25-29)54-20-19-53-18-17-52-16-15-50-4/h7-14,21-26,46H,15-20H2,1-6H3,(H,41,42,45)(H2,43,44,47)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 14n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM347463
PNG
(N-(5-(tert-Butyl)-2-methoxy-3-(3-(4-((2-((3-methox...)
Show SMILES CNc1cc(cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(OCCOCCOCCOC)c4)n3)c3ccccc23)c1OC)C(C)(C)C
Show InChI InChI=1S/C41H50N6O8/c1-41(2,3)27-22-34(42-4)38(51-7)35(23-27)46-40(48)45-33-12-13-36(32-11-9-8-10-31(32)33)55-37-14-15-43-39(47-37)44-28-24-29(50-6)26-30(25-28)54-21-20-53-19-18-52-17-16-49-5/h8-15,22-26,42H,16-21H2,1-7H3,(H,43,44,47)(H2,45,46,48)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 14n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256548
PNG
(US9481648, 47 | US9790174, Example 47)
Show SMILES COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(C(N)=O)c4OC)C(C)(C)C)c4ccccc34)ccn2)cc(c1)C(=O)NCCN1CCOCC1
Show InChI InChI=1S/C42H47N7O7/c1-42(2,3)27-22-33(39(43)50)38(54-5)35(23-27)48-41(52)47-34-10-11-36(32-9-7-6-8-31(32)34)56-29-12-13-44-37(25-29)46-28-20-26(21-30(24-28)53-4)40(51)45-14-15-49-16-18-55-19-17-49/h6-13,20-25H,14-19H2,1-5H3,(H2,43,50)(H,44,46)(H,45,51)(H2,47,48,52)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 15n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256547
PNG
(US9481648, 46 | US9790174, Example 46)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(C(=O)NCCN(C)C)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C45H57N7O9/c1-45(2,3)30-25-36(42(53)46-17-18-52(4)5)41(57-8)38(26-30)50-44(54)49-37-13-14-39(35-12-10-9-11-34(35)37)61-40-15-16-47-43(51-40)48-31-27-32(56-7)29-33(28-31)60-24-23-59-22-21-58-20-19-55-6/h9-16,25-29H,17-24H2,1-8H3,(H,46,53)(H,47,48,51)(H2,49,50,54)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 15n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256552
PNG
(US9481648, 51 | US9790174, Example 51)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(C(=O)NC5COC5)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C44H52N6O10/c1-44(2,3)28-21-35(41(51)46-30-26-58-27-30)40(55-6)37(22-28)49-43(52)48-36-11-12-38(34-10-8-7-9-33(34)36)60-39-13-14-45-42(50-39)47-29-23-31(54-5)25-32(24-29)59-20-19-57-18-17-56-16-15-53-4/h7-14,21-25,30H,15-20,26-27H2,1-6H3,(H,46,51)(H,45,47,50)(H2,48,49,52)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 15n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256537
PNG
(US9481648, 36 | US9790174, Example 36)
Show SMILES COCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(NS(C)(=O)=O)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C39H46N6O9S/c1-39(2,3)25-20-32(36(51-6)33(21-25)45-55(7,47)48)43-38(46)42-31-12-13-34(30-11-9-8-10-29(30)31)54-35-14-15-40-37(44-35)41-26-22-27(50-5)24-28(23-26)53-19-18-52-17-16-49-4/h8-15,20-24,45H,16-19H2,1-7H3,(H,40,41,44)(H2,42,43,46)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 16n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM347469
PNG
(N-(5-(tert-Butyl)-3-(3-(2,3-dichloro-4-((2-((3-met...)
Show SMILES CNc1cc(cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(OCCOCCOCCOC)c4)n3)c(Cl)c2Cl)c1OC)C(C)(C)C
Show InChI InChI=1S/C37H46Cl2N6O8/c1-37(2,3)23-18-28(40-4)34(49-7)29(19-23)44-36(46)43-27-8-9-30(33(39)32(27)38)53-31-10-11-41-35(45-31)42-24-20-25(48-6)22-26(21-24)52-17-16-51-15-14-50-13-12-47-5/h8-11,18-22,40H,12-17H2,1-7H3,(H,41,42,45)(H2,43,44,46)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 18n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM256581
PNG
(US9481648, 80 | US9790174, Example 80)
Show SMILES COc1c(NC(=O)Nc2ccc(Oc3ccnc(NCc4ccccn4)c3)c3ccccc23)cc(cc1C(=O)NC1COC1)C(C)(C)C
Show InChI InChI=1S/C37H38N6O5/c1-37(2,3)23-17-29(35(44)41-25-21-47-22-25)34(46-4)31(18-23)43-36(45)42-30-12-13-32(28-11-6-5-10-27(28)30)48-26-14-16-39-33(19-26)40-20-24-9-7-8-15-38-24/h5-19,25H,20-22H2,1-4H3,(H,39,40)(H,41,44)(H2,42,43,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 18n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The following two assay variants can be used for determination of p38 MAPKα inhibition.Method 1The inhibitory activities of test compounds again...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256535
PNG
(US9481648, 34 | US9790174, Example 34)
Show SMILES COCCOCCOCCOc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(C(N)=O)c4OC)C(C)(C)C)c4ccccc34)ccn2)cc(OC)c1
Show InChI InChI=1S/C42H49N5O9/c1-42(2,3)27-21-34(40(43)48)39(52-6)36(22-27)47-41(49)46-35-11-12-37(33-10-8-7-9-32(33)35)56-29-13-14-44-38(26-29)45-28-23-30(51-5)25-31(24-28)55-20-19-54-18-17-53-16-15-50-4/h7-14,21-26H,15-20H2,1-6H3,(H2,43,48)(H,44,45)(H2,46,47,49)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 19n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256530
PNG
(US9481648, 29 | US9790174, Example 29)
Show SMILES CNC(=O)c1cc(cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(OCCOCCOCCOC)c4)c3)c3ccccc23)c1OC)C(C)(C)C
Show InChI InChI=1S/C43H51N5O9/c1-43(2,3)28-22-35(41(49)44-4)40(53-7)37(23-28)48-42(50)47-36-12-13-38(34-11-9-8-10-33(34)36)57-30-14-15-45-39(27-30)46-29-24-31(52-6)26-32(25-29)56-21-20-55-19-18-54-17-16-51-5/h8-15,22-27H,16-21H2,1-7H3,(H,44,49)(H,45,46)(H2,47,48,50)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 19n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM347462
PNG
(3-((4-((4-(3-(5-(tert-Butyl)-2-methoxy-3-(methylsu...)
Show SMILES CNc1cc(cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(c4)C(=O)NCCOCCOCCOC)c3)c3ccccc23)c1OC)C(C)(C)C
Show InChI InChI=1S/C43H52N6O8/c1-43(2,3)29-24-36(44-4)40(54-7)37(25-29)49-42(51)48-35-12-13-38(34-11-9-8-10-33(34)35)57-31-14-15-45-39(27-31)47-30-22-28(23-32(26-30)53-6)41(50)46-16-17-55-20-21-56-19-18-52-5/h8-15,22-27,44H,16-21H2,1-7H3,(H,45,47)(H,46,50)(H2,48,49,51)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 20n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM256547
PNG
(US9481648, 46 | US9790174, Example 46)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(C(=O)NCCN(C)C)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C45H57N7O9/c1-45(2,3)30-25-36(42(53)46-17-18-52(4)5)41(57-8)38(26-30)50-44(54)49-37-13-14-39(35-12-10-9-11-34(35)37)61-40-15-16-47-43(51-40)48-31-27-32(56-7)29-33(28-31)60-24-23-59-22-21-58-20-19-55-6/h9-16,25-29H,17-24H2,1-8H3,(H,46,53)(H,47,48,51)(H2,49,50,54)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 20n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256598
PNG
(US9481648, 84(h) | US9790174, Example 84(h))
Show SMILES CNC(=O)c1cc(cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(CO)cc(OC)c4)c3)c3ccccc23)c1OC)C(C)(C)C
Show InChI InChI=1S/C37H39N5O6/c1-37(2,3)23-17-29(35(44)38-4)34(47-6)31(18-23)42-36(45)41-30-11-12-32(28-10-8-7-9-27(28)30)48-25-13-14-39-33(20-25)40-24-15-22(21-43)16-26(19-24)46-5/h7-20,43H,21H2,1-6H3,(H,38,44)(H,39,40)(H2,41,42,45)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 21n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM347470
PNG
(N-(5-(tert-Butyl)-2-methoxy-3-(3-(4-((2-((3-methox...)
Show SMILES CNc1cc(cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(OCCOCCOCCOC)c4)c3)c3ccccc23)c1OC)C(C)(C)C
Show InChI InChI=1S/C42H51N5O8/c1-42(2,3)28-22-36(43-4)40(51-7)37(23-28)47-41(48)46-35-12-13-38(34-11-9-8-10-33(34)35)55-30-14-15-44-39(27-30)45-29-24-31(50-6)26-32(25-29)54-21-20-53-19-18-52-17-16-49-5/h8-15,22-27,43H,16-21H2,1-7H3,(H,44,45)(H2,46,47,48)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 21n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256556
PNG
(US9481648, 55 | US9790174, Example 55)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(c4OC)S(N)(=O)=O)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C40H48N6O10S/c1-40(2,3)26-21-33(37(52-6)35(22-26)57(41,48)49)45-39(47)44-32-11-12-34(31-10-8-7-9-30(31)32)56-36-13-14-42-38(46-36)43-27-23-28(51-5)25-29(24-27)55-20-19-54-18-17-53-16-15-50-4/h7-14,21-25H,15-20H2,1-6H3,(H2,41,48,49)(H,42,43,46)(H2,44,45,47)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 22n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256584
PNG
(US9481648, 83(a) | US9790174, Example 83(a))
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(NS(C)(=O)=O)c4-c4ccccc4)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C46H52N6O9S/c1-46(2,3)32-26-39(43(31-12-8-7-9-13-31)40(27-32)52-62(6,54)55)50-45(53)49-38-16-17-41(37-15-11-10-14-36(37)38)61-42-18-19-47-44(51-42)48-33-28-34(57-5)30-35(29-33)60-25-24-59-23-22-58-21-20-56-4/h7-19,26-30,52H,20-25H2,1-6H3,(H,47,48,51)(H2,49,50,53)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 22n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256567
PNG
(US9481648, 66 | US9790174, Example 66)
Show SMILES COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(NS(C)(=O)=O)c4OC)C(C)(C)C)c4ccccc34)ccn2)cc(c1)C(=O)NCCCN1CCOCC1
Show InChI InChI=1S/C43H51N7O8S/c1-43(2,3)29-24-36(40(56-5)37(25-29)49-59(6,53)54)48-42(52)47-35-12-13-38(34-11-8-7-10-33(34)35)58-31-14-16-44-39(27-31)46-30-22-28(23-32(26-30)55-4)41(51)45-15-9-17-50-18-20-57-21-19-50/h7-8,10-14,16,22-27,49H,9,15,17-21H2,1-6H3,(H,44,46)(H,45,51)(H2,47,48,52)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 23n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256578
PNG
(US9481648, 77 | US9790174, Example 77)
Show SMILES COCCOCCOCCOc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(C(=O)NC5COC5)c4OC)C(C)(C)C)c4ccccc34)ccn2)cc(OC)c1
Show InChI InChI=1S/C45H53N5O10/c1-45(2,3)29-21-37(43(51)48-31-27-58-28-31)42(55-6)39(22-29)50-44(52)49-38-11-12-40(36-10-8-7-9-35(36)38)60-32-13-14-46-41(26-32)47-30-23-33(54-5)25-34(24-30)59-20-19-57-18-17-56-16-15-53-4/h7-14,21-26,31H,15-20,27-28H2,1-6H3,(H,46,47)(H,48,51)(H2,49,50,52)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 23n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM142019
PNG
(US8927563, I | US9481648, 16 | US9790174, Example ...)
Show SMILES COCCOCCOCCNC(=O)c1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(NS(C)(=O)=O)c4OC)C(C)(C)C)c4ccccc34)n2)cc(c1)C#C
Show InChI InChI=1S/C43H49N7O9S/c1-8-28-23-29(40(51)44-17-18-57-21-22-58-20-19-55-5)25-31(24-28)46-41-45-16-15-38(49-41)59-37-14-13-34(32-11-9-10-12-33(32)37)47-42(52)48-35-26-30(43(2,3)4)27-36(39(35)56-6)50-60(7,53)54/h1,9-16,23-27,50H,17-22H2,2-7H3,(H,44,51)(H,45,46,49)(H2,47,48,52)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 24n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM256535
PNG
(US9481648, 34 | US9790174, Example 34)
Show SMILES COCCOCCOCCOc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(C(N)=O)c4OC)C(C)(C)C)c4ccccc34)ccn2)cc(OC)c1
Show InChI InChI=1S/C42H49N5O9/c1-42(2,3)27-21-34(40(43)48)39(52-6)36(22-27)47-41(49)46-35-11-12-37(33-10-8-7-9-32(33)35)56-29-13-14-44-38(26-29)45-28-23-30(51-5)25-31(24-28)55-20-19-54-18-17-53-16-15-50-4/h7-14,21-26H,15-20H2,1-6H3,(H2,43,48)(H,44,45)(H2,46,47,49)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 25n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The following two assay variants can be used for determination of p38 MAPKα inhibition.Method 1The inhibitory activities of test compounds again...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM347486
PNG
(3-((4-((4-(3-(5-(tert-Butyl)-2-methoxy-3-(methylsu...)
Show SMILES CNc1cc(cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(c4)C(=O)NCCN4CCOCC4)c3)c3ccccc23)c1OC)C(C)(C)C
Show InChI InChI=1S/C42H49N7O6/c1-42(2,3)28-23-35(43-4)39(53-6)36(24-28)48-41(51)47-34-11-12-37(33-10-8-7-9-32(33)34)55-30-13-14-44-38(26-30)46-29-21-27(22-31(25-29)52-5)40(50)45-15-16-49-17-19-54-20-18-49/h7-14,21-26,43H,15-20H2,1-6H3,(H,44,46)(H,45,50)(H2,47,48,51)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 26n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM256530
PNG
(US9481648, 29 | US9790174, Example 29)
Show SMILES CNC(=O)c1cc(cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(OCCOCCOCCOC)c4)c3)c3ccccc23)c1OC)C(C)(C)C
Show InChI InChI=1S/C43H51N5O9/c1-43(2,3)28-22-35(41(49)44-4)40(53-7)37(23-28)48-42(50)47-36-12-13-38(34-11-9-8-10-33(34)36)57-30-14-15-45-39(27-30)46-29-24-31(52-6)26-32(25-29)56-21-20-55-19-18-54-17-16-51-5/h8-15,22-27H,16-21H2,1-7H3,(H,44,49)(H,45,46)(H2,47,48,50)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 26n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The following two assay variants can be used for determination of p38 MAPKα inhibition.Method 1The inhibitory activities of test compounds again...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM256511
PNG
(US9481648, 9 | US9790174, Example 9)
Show SMILES CNC(=O)c1cc(cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(cc(c4)C(=O)NCCN4CCOCC4)C#C)n3)c3ccccc23)c1OC)C(C)(C)C
Show InChI InChI=1S/C43H46N8O6/c1-7-27-22-28(39(52)45-16-17-51-18-20-56-21-19-51)24-30(23-27)47-41-46-15-14-37(50-41)57-36-13-12-34(31-10-8-9-11-32(31)36)48-42(54)49-35-26-29(43(2,3)4)25-33(38(35)55-6)40(53)44-5/h1,8-15,22-26H,16-21H2,2-6H3,(H,44,53)(H,45,52)(H,46,47,50)(H2,48,49,54)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 27n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256597
PNG
(US9481648, 84(g) | US9790174, Example 84(g))
Show SMILES COc1cc(CO)cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(C(N)=O)c4OC)C(C)(C)C)c4ccccc34)ccn2)c1
Show InChI InChI=1S/C36H37N5O6/c1-36(2,3)22-16-28(34(37)43)33(46-5)30(17-22)41-35(44)40-29-10-11-31(27-9-7-6-8-26(27)29)47-24-12-13-38-32(19-24)39-23-14-21(20-42)15-25(18-23)45-4/h6-19,42H,20H2,1-5H3,(H2,37,43)(H,38,39)(H2,40,41,44)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 28n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256560
PNG
(US9481648, 59 | US9790174, Example 59)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(-c5nnco5)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C42H47N7O9/c1-42(2,3)27-21-33(39-49-44-26-57-39)38(53-6)35(22-27)47-41(50)46-34-11-12-36(32-10-8-7-9-31(32)34)58-37-13-14-43-40(48-37)45-28-23-29(52-5)25-30(24-28)56-20-19-55-18-17-54-16-15-51-4/h7-14,21-26H,15-20H2,1-6H3,(H,43,45,48)(H2,46,47,50)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 28n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM256517
PNG
(US9481648, 15 | US9790174, Example 15)
Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(NS(C)(=O)=O)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OCCOCCOCCN(C)C)c1
Show InChI InChI=1S/C42H53N7O9S/c1-42(2,3)28-23-35(39(54-7)36(24-28)48-59(8,51)52)46-41(50)45-34-13-14-37(33-12-10-9-11-32(33)34)58-38-15-16-43-40(47-38)44-29-25-30(53-6)27-31(26-29)57-22-21-56-20-19-55-18-17-49(4)5/h9-16,23-27,48H,17-22H2,1-8H3,(H,43,44,47)(H2,45,46,50)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 28n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The following two assay variants can be used for determination of p38 MAPKα inhibition.Method 1The inhibitory activities of test compounds again...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM256515
PNG
(US9481648, 13 | US9790174, Example 13)
Show SMILES CNC(=O)c1cc(cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(OCCOCCOCCOC)c4)n3)c3ccccc23)c1OC)C(C)(C)C
Show InChI InChI=1S/C42H50N6O9/c1-42(2,3)27-22-33(39(49)43-4)38(53-7)35(23-27)47-41(50)46-34-12-13-36(32-11-9-8-10-31(32)34)57-37-14-15-44-40(48-37)45-28-24-29(52-6)26-30(25-28)56-21-20-55-19-18-54-17-16-51-5/h8-15,22-26H,16-21H2,1-7H3,(H,43,49)(H,44,45,48)(H2,46,47,50)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 28n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The following two assay variants can be used for determination of p38 MAPKα inhibition.Method 1The inhibitory activities of test compounds again...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM256534
PNG
(US9481648, 33 | US9790174, Example 33)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(C(=O)NC5CC5)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C44H52N6O9/c1-44(2,3)28-23-35(41(51)46-29-11-12-29)40(55-6)37(24-28)49-43(52)48-36-13-14-38(34-10-8-7-9-33(34)36)59-39-15-16-45-42(50-39)47-30-25-31(54-5)27-32(26-30)58-22-21-57-20-19-56-18-17-53-4/h7-10,13-16,23-27,29H,11-12,17-22H2,1-6H3,(H,46,51)(H,45,47,50)(H2,48,49,52)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 28n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256517
PNG
(US9481648, 15 | US9790174, Example 15)
Show SMILES COc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(NS(C)(=O)=O)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OCCOCCOCCN(C)C)c1
Show InChI InChI=1S/C42H53N7O9S/c1-42(2,3)28-23-35(39(54-7)36(24-28)48-59(8,51)52)46-41(50)45-34-13-14-37(33-12-10-9-11-32(33)34)58-38-15-16-43-40(47-38)44-29-25-30(53-6)27-31(26-29)57-22-21-56-20-19-55-18-17-49(4)5/h9-16,23-27,48H,17-22H2,1-8H3,(H,43,44,47)(H2,45,46,50)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 28n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256540
PNG
(US9481648, 39 | US9790174, Example 39)
Show SMILES CNC(=O)c1cc(cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(cc(c4)C(=O)NCCN4CCOCC4)C#C)c3)c3ccccc23)c1OC)C(C)(C)C
Show InChI InChI=1S/C44H47N7O6/c1-7-28-22-29(41(52)47-16-17-51-18-20-56-21-19-51)24-31(23-28)48-39-27-32(14-15-46-39)57-38-13-12-36(33-10-8-9-11-34(33)38)49-43(54)50-37-26-30(44(2,3)4)25-35(40(37)55-6)42(53)45-5/h1,8-15,22-27H,16-21H2,2-6H3,(H,45,53)(H,46,48)(H,47,52)(H2,49,50,54)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 29n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Tyrosine-protein kinase SYK


(Homo sapiens (Human))
BDBM256521
PNG
(US9481648, 20 | US9790174, Example 20)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(C(N)=O)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C41H48N6O9/c1-41(2,3)26-21-32(38(42)48)37(52-6)34(22-26)46-40(49)45-33-11-12-35(31-10-8-7-9-30(31)33)56-36-13-14-43-39(47-36)44-27-23-28(51-5)25-29(24-27)55-20-19-54-18-17-53-16-15-50-4/h7-14,21-25H,15-20H2,1-6H3,(H2,42,48)(H,43,44,47)(H2,45,46,49)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 29n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256599
PNG
(US9481648, 85(a) | US9790174, Example 85(a))
Show SMILES COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(NS(C)(=O)=O)c4OC)C(C)(C)C)c4ccccc34)ccn2)cc(c1)C(=O)NCC(=O)N1CCOCC1
Show InChI InChI=1S/C42H47N7O9S/c1-42(2,3)27-21-34(39(56-5)35(22-27)48-59(6,53)54)47-41(52)46-33-11-12-36(32-10-8-7-9-31(32)33)58-29-13-14-43-37(24-29)45-28-19-26(20-30(23-28)55-4)40(51)44-25-38(50)49-15-17-57-18-16-49/h7-14,19-24,48H,15-18,25H2,1-6H3,(H,43,45)(H,44,51)(H2,46,47,52)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 29n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM256525
PNG
(US9481648, 24 | US9790174, Example 24)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(NS(C)(=O)=O)cc(c4)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C40H48N6O9S/c1-40(2,3)27-21-28(23-30(22-27)46-56(6,48)49)43-39(47)44-35-11-12-36(34-10-8-7-9-33(34)35)55-37-13-14-41-38(45-37)42-29-24-31(51-5)26-32(25-29)54-20-19-53-18-17-52-16-15-50-4/h7-14,21-26,46H,15-20H2,1-6H3,(H,41,42,45)(H2,43,44,47)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 30n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The following two assay variants can be used for determination of p38 MAPKα inhibition.Method 1The inhibitory activities of test compounds again...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM256577
PNG
(US9481648, 76 | US9790174, Example 76)
Show SMILES COCCOCCOCCOc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(C(=O)NCCN(C)C)c4OC)C(C)(C)C)c4ccccc34)ccn2)cc(OC)c1
Show InChI InChI=1S/C46H58N6O9/c1-46(2,3)31-25-38(44(53)48-17-18-52(4)5)43(57-8)40(26-31)51-45(54)50-39-13-14-41(37-12-10-9-11-36(37)39)61-33-15-16-47-42(30-33)49-32-27-34(56-7)29-35(28-32)60-24-23-59-22-21-58-20-19-55-6/h9-16,25-30H,17-24H2,1-8H3,(H,47,49)(H,48,53)(H2,50,51,54)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 31n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM256563
PNG
(US9481648, 62 | US9790174, Example 62)
Show SMILES COCCOCCOCCNC(=O)c1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(cc(c4)C(C)(C)C)C(N)=O)c4ccccc34)ccn2)cc(c1)C#C
Show InChI InChI=1S/C43H46N6O7/c1-6-28-21-30(41(51)46-15-16-54-19-20-55-18-17-53-5)25-32(22-28)47-39-27-34(13-14-45-39)56-38-12-11-37(35-9-7-8-10-36(35)38)49-42(52)48-33-24-29(40(44)50)23-31(26-33)43(2,3)4/h1,7-14,21-27H,15-20H2,2-5H3,(H2,44,50)(H,45,47)(H,46,51)(H2,48,49,52)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 32n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The following two assay variants can be used for determination of p38 MAPKα inhibition.Method 1The inhibitory activities of test compounds again...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 14


(Homo sapiens (Human))
BDBM256521
PNG
(US9481648, 20 | US9790174, Example 20)
Show SMILES COCCOCCOCCOc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(cc(C(N)=O)c4OC)C(C)(C)C)c4ccccc34)n2)cc(OC)c1
Show InChI InChI=1S/C41H48N6O9/c1-41(2,3)26-21-32(38(42)48)37(52-6)34(22-26)46-40(49)45-33-11-12-35(31-10-8-7-9-30(31)33)56-36-13-14-43-39(47-36)44-27-23-28(51-5)25-29(24-27)55-20-19-54-18-17-53-16-15-50-4/h7-14,21-25H,15-20H2,1-6H3,(H2,42,48)(H,43,44,47)(H2,45,46,49)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 33n/an/an/an/an/an/a



Respivert Limited; Topivert Pharma Limited

US Patent


Assay Description
The following two assay variants can be used for determination of p38 MAPKα inhibition.Method 1The inhibitory activities of test compounds again...


US Patent US9790174 (2017)


BindingDB Entry DOI: 10.7270/Q2M61NCF
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 318 total )  |  Next  |  Last  >>
* indicates data uncertainty>20%